Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Soft Tissue ApproximationElevation of SubdermisElevation of Underlying Muscle
Interventions
DEVICE

MyEllevate Procedure

"The defined study area will be identified and may be marked with a surgical marker.~A local tumescent anesthetic, such as lidocaine, will be injected to the area prior to the procedure. The MyEllevate® device will be used in accordance with the Instructions for Use (IFU) manual for soft tissue approximation and elevation of sub dermis and underlying muscle of the submentum and jawline."

Trial Locations (2)

10306

Aesthetic Pavilion Ambulatory Surgery Center, Staten Island

07042

New Jersey Plastic Surgery, Montclair

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cynosure, Inc.

INDUSTRY

NCT05590039 - Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure | Biotech Hunter | Biotech Hunter